Latvia
Industry
Latvian pharmaceutical company Grindeks has announced plans to increase revenues by over 30% in 2010 to LVL30mn (US$132mn), with a strategy of strengthening its position in current...
2010-04-27Industry
Latvian pharmaceutical company Olainfarm has announced plans to open a representative office in Bangkok during 2010, while also expanding into Central Asian markets. BMI considers...
2010-03-15BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,...
2010-03-15Industry
BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected...
2010-01-05Industry
BMI believes that pharmaceutical sales in Latvia is likely to be the worst hit among our 71-country pharmaceutical market universe. Data over the first 10 months of 2009 varies, although...
2009-12-24Industry
BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings....
2009-10-30Industry
Pharmaceutical sales in the Baltic States continue to be heavily affected by the economic crisis, as six-month data for the early part of 2009 show contractions in Latvia and Lithuania,...
2009-09-30Industry
Pharmaceuticals sales in Latvia showed negative year-on-year (y-o-y) growth during the second quarter of 2008, concurrent with the release of abysmal GDP data and rocketing unemployment....
2009-09-02


